Agile Therapeutics Has Priced Its Public Offering Of 1.89M, Together With Accompanying Common Stock Warrants, At $3.9551 Per Share (Or Pre-funded Warrant) And Accompanying Warrants, For A Gross Proceed Of Approximately $7.5M
Portfolio Pulse from Benzinga Newsdesk
Agile Therapeutics has priced its public offering of 1.89 million shares, along with accompanying common stock warrants, at $3.9551 per share, raising approximately $7.5 million in gross proceeds.
May 23, 2023 | 8:09 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Agile Therapeutics' public offering of 1.89 million shares and accompanying warrants is priced at $3.9551 per share, raising $7.5 million in gross proceeds.
The public offering will raise $7.5 million in gross proceeds for Agile Therapeutics. This may have a neutral short-term impact on the stock price, as the market has already priced in the offering. However, the additional funds could be used for growth and expansion, which may have a positive impact on the company's long-term prospects.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100